IMAPAC - Biologics World China 2012: China’s biggest and most influential gathering of biopharmaceutical and biologic companies

IMAPAC Events» Business Conferences » Biologics World China 2012: China’s biggest and most influential gathering of biopharmaceutical and biologic companies

Endorsing Organisations

TARGET YOUR
MARKET NOW!
Contact
Neville De Nazareth

Linkedin Group

Join BioManufacturing World Linkedin Group

Biologics World China 2012 is in its 3rd year running and we are proud to bring you China's largest biopharmaceutical industry gathering, bringing together decision makers across C level management, R&D and manufacturing in the realms of Biologic drugs, Biosimilars, Vaccines and Blood/Plasma products! This year topics will include: Regulatory guidelines and pathways for biosimilars in China Pricing mechanism and distribution strategies of biosimilars in China Best practices in process development and engineering for mAbs and vaccines Scale-up for downstream processing Innovative cell lines for mAb and vaccine development Case studies on novel or next generation biologics WHO pre-qualification for Chinese vaccines and biologics IP management of biologic products in China Implementing quality control throughout entire bioprocess -> Meet our adivsory board -> Find out more about the programme -> Meet the speakers	Featured Speakers
		Dr Dorothee Ambrosius, SVP Global Process Science, Biopharamceuticals Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
		Wu Jun, Visiting Professor, SFDA Training Center, China
		Dr Jiang Fei, Research and Development, 3sBio, China
	DOWNLOAD BROCHURE NOW!

Distinguished Speaker Faculty Include:

Dr Michael Yu CEO Innovent Biologics, China	Dr Allan Riting Liu, Vice President, Wanbang Biopharma, China	Robert Chen, Senior Director, Global Strategy & Partnering, Genor Biopharma, China
Dr Saul Mashaal, Chairman, Acertus Pharma, USA and Co-Chair, Vanir BioVice, Singapore	Zoe Wang, Partner, June He Law Offices, China	Dr Jin-San Yoo, President & CEO, PharmAbcine, South Korea
Dr Scott Liu, CEO, Henlius Biopharmaceuticals Inc, China	Lily Peng, Chairman, Chinese-Taipei Biotechnology Service Association, Taiwan	Dr Ke Wu, President & Founder, BravoBio, China
Kang Li, Head of Biologics, Beigene, China	Helen Yang, Director Investor Relations and International Business Development, Sinovac Biotech Ltd, China	Yong Yin, CSO, R&D, Shanghai MT Biotech Co. Ltd, China
Dr Joe Zhou CEO Genor Biopharma, China	Jiawen Han, Director, Biologics Innovation Center, AstraZeneca, China	Grace Xu, Vice President, Bristol-Myers Squibb, China
Liang Xu, Director of Vaccine Manufacturing, Merck Co, United States	Matthias Brand, Market Development Manager, BD Advanced Bioprocessing, Singapore	Youlin Wu, CEO, Teruisi Pharmaceutical Inc, China
Richard Yeh, Head of Regional Healthcare Asia Pacific, Citibank, Hong Kong	Jian Dong, Vice President, Shanghai Celgen Bio-pharmaceutical, China	Ming Wang, President and COO, Gan&Lee Pharmaceutical, China
Feng Li, CEO, Beijing Mab-Works, China	Chen Yu, Project Manager (Asia), Sartorius Stedim, Singapore	Jeffrey Su, CSO, Cytovance Biologicals, United States
Zheru Zhang, Vice President R&D, Celltrion, South Korea	DQ Wang, Director of Innovation Management, Global CMC, Bayer, China	Ian Randsome, Asia Pacific Director, TAP Biosystems, UK
Henry Weichert, Head of Product Management Process Analytics, Sartorius Stedim Biotech, Germany	Xiangdong Chai, CEO & President, Shenzhen Neptunus Interlong Bio-Tech Co., Ltd, China

Sales and Marketing Opportunities at 3rd Annual Biologics World China 2012

Your business is about much more than just knocking on doors. Your marketing strategy is much more than a lead generator. To generate sales, you need brand credibility and a genuine leadership position. To generate awareness and response, you need targeted, decision-maker focused, geographically effective marketing. To generate profits, you need marketing service of Biologic World China 2012!

Biologics World China 2012 will give you the unique opportunity to position your business in front of decision makers from the world's largest and most innovative companies involved in biomanufacturing, cell culture development and engineering, vaccine R&D and manufacturing, investment and financing, stem cells, blood products and many more!

>> Who to meet at the event
>> Download of 2012 sponsorship prospectus
>> Download of 2011 post show report

For more details on the sponsorship and exhibition opportunities, please contact Neville de Nazareth at neville.nazareth@imapac.com or +65 6493 1598.